共 33 条
- [31] The role of cetuximab in induction chemotherapy: Comparison of APF-C (nab-paclitaxel, cisplatin, 5-FU + cetuximab) with APF, both followed by chemoradiation therapy (CRT), in patients with locally advanced head and neck squamous cell carcinoma (HNSCC). JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
- [32] Phase II induction cetuximab (C25), paclitaxel (P), and carboplatin (C) followed by chemoradiation with C255, P, C, and RT 68-72Gy for stage III/IV head and neck squamous cancer: Primary site organ preservation and disease control at 2 years (ECOG, E2303) JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
- [33] High Dose [F-18]-Fluorodeoxyglucose (FDG) PET/CT Based Imaged-Guided Intensity-Modulated Radiotherapy (IG-IMRT) with Concurrent paclitaxel (P) and Carboplatin (C) in Locally Advanced Non-Small-Cell Lung Cancer (LANSCLC): A Dose-Finding Phase I Study INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : S146 - S146